The In Vitro Assessments of Antimicrobial Activity (IVAAA) master indefinite-delivery/indefinite-quantity contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide research services assessing the antimicrobial activity of substances against infectious agents. The University of Texas Health Science Center of San Antonio is the prime contractor for this multiple award contract vehicle with a potential value of $30 million and a period of performance through January 2026.
Under various firm fixed price delivery orders issued against the IVAAA, the University of Texas Health Science Center of San Antonio conducts in vitro screening and assessments of experimental antibacterial and antifungal substances. This includes determining the inhibitory effect of such substances against bacterial and fungal pathogens through MIC and MIC 90 assays. Services are performed at the prime contractor's facilities in San Antonio, Texas under orders valued from approximately $100,000 to $150,000 each. The work supports the National Institute of Allergy and Infectious Diseases' programs researching potential new treatments for infectious diseases such as those caused by drug-resistant bacteria and fungi. No set-aside designations or subcontracting arrangements are specified in the provided task orders issued to date.
Generated 2/8/24, 9:16 AM